Cell shape is critical for function of individual cells within an organism, as well as cells that function as part of a tissue or organ. We use Drosophila tracheal terminal cells, a component of the insect respiratory system, to investigate the molecular mechanisms that participate in controlling two conserved types of cellular morphology: branching and tube formation (lumenogenesis). Terminal cells are located at the tips of a network of branched tubes that functions to deliver oxygen to internal tissues1 and have an elaborate branched morphology which depends on an FGF signaling pathway that is controlled by local oxygen levels within target tissues2. Terminal cell branches are thin tubes, with a gas-filled subcellular lumen running through each branch. The distinct cellular architectures of terminal cells, along with the ease by which genetic analysis can be performed in Drosophila, make these cells an excellent model for investigating mechanisms of cellular outgrowth, branching, and intracellular tube formation. Terminal cells have proved a useful model for understanding some of the signaling pathways leading to branched cell differentiation, outgrowth, and maturation2-4. Using this system unbiased, forward genetic screens for cell morphogenesis mutants have been performed, yielding insights into mechanisms controlling cell shape5,6. For instance, these screens have revealed that a specific RabGAP is required for cytoskeletal polarity and vesicle trafficking in lumen formation and positioning7; that integrin-mediated adhesion is required for branch stability8; and that epithelial PAR-polarity proteins regulate polarized membrane trafficking required for both branching and lumen formation9. Other studies in terminal cells have shown that asymmetric actin accumulation and microtubule organization is required for cell elongation and lumenogenesis10. Thus, diverse, conserved cell biological mechanisms contribute to terminal cell morphogenesis.
Here, we describe a method to rapidly fix intact third-instar Drosophila larvae for analysis of terminal cell branching and lumen formation. This protocol can also be carried out on both first and second instar animals. Key to this technique is the ability to visualize terminal cells that are genetically labeled by fluorescent protein expression directly through the larval cuticle of intact animals. Since this procedure does not require any post-fixation manipulations, such as antibody staining, to observe the cells, it is well suited to high throughput analysis, including genetic or drug screening. Fluorescent protein expression reveals the structure of the cytoplasmically-filled branches. Tube formation can be monitored in parallel using brightfield microscopy to identify the gas-filled lumen, which contrasts with the surrounding fluid-filled tissues.
Included in this protocol is the method for generating genetic mosaics based on the MARCM system11, to produce homozygous mutant terminal cells labeled with fluorescent proteins in otherwise unlabeled animals. This is necessary, since terminal cells only elaborate their complex structures relatively late in development; genetic mosaics allow for bypass of gene requirements in other tissues earlier in development. To generate MARCM clones, trachea are labeled using the tracheal-specific driver breathless (btl)12. Described here is the protocol for the Drosophila X chromosome; for other chromosomes, a similar procedure can be used, with genetic reagents appropriate to the chromosome being examined. Here, trachea are labeled by expression of a cytoplasmically localized GFP, but the procedure works equally well with expression of other fluorescent proteins, such as DsRed.
Additionally, we have included a method to quantify branching patterns and lumen formation in terminal cells, based on methods developed for characterizing neuronal branch patterns13. This kind of quantitative data can be critical in discerning the precise role of genes in the branching or lumenogenesis process, as well as allowing for direct comparisons between different mutants9.